The Curing Coma Campaign and the Future of Coma Research.


Journal

Seminars in neurology
ISSN: 1098-9021
Titre abrégé: Semin Neurol
Pays: United States
ID NLM: 8111343

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 30 6 2022
medline: 16 9 2022
entrez: 29 6 2022
Statut: ppublish

Résumé

Recovery from coma or disordered consciousness is a central issue in patients with acute brain injuries such as stroke, trauma, cardiac arrest, and brain infections. Yet, major gaps remain in the scientific underpinnings of coma and this has led to inaccuracy in prognostication and limited interventions for coma recovery. Even so, recent studies have begun to elucidate mechanisms of consciousness early and prolonged after acute brain injury and some pilot interventions have begun to be tested. The importance and scope of this led in 2019 to the development of the Curing Coma Campaign, an initiative of the Neurocritical Care Society designed to provide a platform for scientific collaboration across the patient care continuum and to empower a community for purposes of research, education, implementation science, and advocacy. Seen as a "grand challenge," the Curing Coma Campaign has developed an infrastructure of scientific working groups and operational modules, along with a 10-year roadmap.

Identifiants

pubmed: 35768013
doi: 10.1055/a-1887-7104
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

393-402

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

DaiWai M Olson (DM)

Department of Neurology, University of Texas Southwestern, Dallas, Texas.

J Claude Hemphill (JC)

Department of Neurology, University of California San Francisco, San Francisco, California.

J Javier Provencio (JJ)

Department of Neurology and Neuroscience, University of Virginia, Charlottesville, Virginia.

Paul Vespa (P)

Departments of Neurosurgery and Neurology, University of California, Los Angeles, Los Angeles, California.

Shraddha Mainali (S)

Department of Neurology, Virginia Commonwealth University, Richmond, Virginia.

Len Polizzotto (L)

Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts.

Keri S Kim (KS)

Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois.

Molly McNett (M)

College of Nursing, The Ohio State University, Columbus, Ohio.

Wendy Ziai (W)

Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery; The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Jose I Suarez (JI)

Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery; The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH